doi:10.3791/52446 (2015). Evidence suggests that small subpopulations of tumor cells maintain a unique self-renewing and differentiation capacity and may be responsible for tumor initiation and/or relapse. Clarifying the mechanisms by which these tumor-initiating cells (TICs) support tumor formation and progression could lead to the development of clinically favorable therapies. Ovarian cancer is a heterogeneous and highly recurrent disease. Recent studies suggest TICs may play an important role in disease biology. We have identified culture conditions that enrich for TICs from ovarian cancer cell lines. Growing either adherent cells or non-adherent ‘floater ’ cells in a low attachment plate with serum free media in the presence of growth f...
Ovarian cancer is one of the most important causes of cancer-related death among women in the world....
Cancer stem cells or tumor-initiating cells (CSC/TICs), which can undergo self-renewal and different...
get chemo-resistant disease is needed for therapeutic approaches to ovarian cancer. Cancer stem cell...
Chemoresistance remains a major clinical obstacle to effective management of ovarian cancer. Cancer ...
Emerging evidence suggests that the capacity of a tumor to grow and propagate is dependent on a smal...
Self-renewing cancer cells are the only cell types within a tumor that have an unlimited ability to ...
Copyright © 2014 Dongqing Wang et al.This is an open access article distributed under theCreativeCom...
Contains fulltext : 175082.pdf (Publisher’s version ) (Open Access)Epithelial ovar...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Due to their self-renewal and tumorigenic properties, tumor-initiating cells (TICs) have been hypoth...
Ovarian cancer is the most lethal gynecological malignancy due to its late detection and high recurr...
Like with many cancers, a single ovarian tumor can display remarkable diversity in genetics, epigene...
Poster Session 5 - Growth Factor Signaling: abstract no. 1102One emerging concept of the development...
Ovarian cancer is the most lethal gynecological malignancy due to its late detection and high recurr...
Cancer stem cells or tumor-initiating cells (CSC/TICs), which can undergo self-renewal and differen...
Ovarian cancer is one of the most important causes of cancer-related death among women in the world....
Cancer stem cells or tumor-initiating cells (CSC/TICs), which can undergo self-renewal and different...
get chemo-resistant disease is needed for therapeutic approaches to ovarian cancer. Cancer stem cell...
Chemoresistance remains a major clinical obstacle to effective management of ovarian cancer. Cancer ...
Emerging evidence suggests that the capacity of a tumor to grow and propagate is dependent on a smal...
Self-renewing cancer cells are the only cell types within a tumor that have an unlimited ability to ...
Copyright © 2014 Dongqing Wang et al.This is an open access article distributed under theCreativeCom...
Contains fulltext : 175082.pdf (Publisher’s version ) (Open Access)Epithelial ovar...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Due to their self-renewal and tumorigenic properties, tumor-initiating cells (TICs) have been hypoth...
Ovarian cancer is the most lethal gynecological malignancy due to its late detection and high recurr...
Like with many cancers, a single ovarian tumor can display remarkable diversity in genetics, epigene...
Poster Session 5 - Growth Factor Signaling: abstract no. 1102One emerging concept of the development...
Ovarian cancer is the most lethal gynecological malignancy due to its late detection and high recurr...
Cancer stem cells or tumor-initiating cells (CSC/TICs), which can undergo self-renewal and differen...
Ovarian cancer is one of the most important causes of cancer-related death among women in the world....
Cancer stem cells or tumor-initiating cells (CSC/TICs), which can undergo self-renewal and different...
get chemo-resistant disease is needed for therapeutic approaches to ovarian cancer. Cancer stem cell...